Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07069400 · ClinicalTrials.gov registry record

An International Observational Study of Adults With Acute Infection

A clinical trial of Infectious Disease, sponsored by University of Minnesota.

Recruiting
Registry status
1,500
Enrollment target
20
Study locations

NCT07069400 is a study of Infectious Disease that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 1,500 participants, below the 6,942-participant average among 18 other Infectious Disease trials with a reported enrollment target (78% lower). The trial reports 20 study locations across 16 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07069400, a study of Infectious Disease, is actively recruiting participants, sponsored by University of Minnesota.

RECRUITING
Registry status
1,500 participants
Enrollment target
20
Study locations

Study Summary

Prospective, longitudinal studies of people with acute infections are essential to understand risk factors, clinical manifestations, pathobiology, and management strategies. Observational studies can provide data necessary to select interventions and strategies for testing in clinical trials and to develop key design features of trials. Observational studies can be particularly important for establishing an early knowledge base after emergence of a new pathogen, as illustrated by the recent emergence of influenza A (H1N1), SARS-CoV-2, and Mpox. This observational study protocol describes collection of data and biospecimens from sites across the world for characterizing acute infections in hospitalized patients. The protocol is designed to study respiratory infections, infections outside the respiratory tract, established infectious diseases, and emerging infectious diseases. Data generated in this study will be used to efficiently characterize acute infectious diseases and plan future clinical trials.

Conditions Studied

Interventions

  • OTHER No intervention

Study Locations (20)

California

  • Stanford University Hospital & Clinics (Site 203-003) - Palo Alto
  • UCSF Medical Center (Site 203-001) - San Francisco

Minnesota

  • University of Minnesota - Minneapolis
  • Mayo Clinic (Site 054-001) - Rochester

New York

  • New York University Langone Health (301-013) - New York
  • Mount Sinai Medical Center (Site 301-012) - New York

North Carolina

  • Duke University (301-006) - Durham
  • Wake Forest Baptist Health (210-001) - Winston-Salem

Arizona

  • Banner University Medical Center Tucson - Tucson

Illinois

  • University of Illinois at Chicago (Site 008-012) - Chicago

Kansas

  • University of Kansas Medical Center (Site 080-044) - Kansas City

Nebraska

  • University of Nebraska Medical Center (Site 080-045) - Omaha

Trial Details

FieldValue
Enrollment Target 1,500 participants
Start Date 2025-08-25
Est. Completion 2027-06-08

Sponsor

University of Minnesota

966 total trials

What the Registry Record Tells You About NCT07069400

The ClinicalTrials.gov registry entry for NCT07069400 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,942-participant average among 18 other Infectious Disease trials with a reported enrollment target (78% lower). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Infectious Disease appearing as the primary indexed condition, and to 1 intervention - of which No intervention is the first listed.

NCT07069400 reports 20 study locations spanning 16 distinct geographic areas - top geographies include California, Minnesota, New York.

Frequently Asked Questions

What is clinical trial NCT07069400 about?

NCT07069400 is a clinical study titled "An International Observational Study of Adults With Acute Infection". Prospective, longitudinal studies of people with acute infections are essential to understand risk factors, clinical manifestations, pathobiology, and management strategies. Observational studies can provide data necessary to select interventions and strategies for testing in clinical trials and to ...

What is the current status of trial NCT07069400?

This trial is currently recruiting. The enrollment target is 1,500 participants. The study started on 2025-08-25. Estimated completion is 2027-06-08.

What conditions does trial NCT07069400 study?

This clinical trial studies the following conditions: Infectious Disease.

What interventions are being tested in trial NCT07069400?

The interventions under investigation include: No intervention (OTHER).

Who is sponsoring clinical trial NCT07069400?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07069400 being conducted?

This trial has 20 study locations across Arizona, California, Illinois, Kansas, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Infectious Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.